1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow CKD: new trials by email Literature Review of CKD trials Research Report on CKD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease Ergocalciferol 50000 UNT, Placebo - CKD, Chronic Kidney Diseases | Phase 4 | Withdrawn | University of Alabama at Birmingham | 2018-01-01 | 2018-03-15 |
Anemia (1) · Anemia, Iron-Deficiency (1) · Renal Insufficiency, Chronic (1)
Anemia, Hypochromic (1) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Iron Deficiencies (1) · Iron Metabolism Disorders (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
University of Alabama at Birmingham (1)
United States (1)